The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ovaleap

300/0.5 international unit(s)/millilitre Solution for injection

Theramex Ireland LimitedEU/1/13/871/001-003

Main Information

Trade NameOvaleap
Active SubstancesFollitropin alfa
Strength300/0.5 international unit(s)/millilitre
Dosage FormSolution for injection
Licence HolderTheramex Ireland Limited
Licence NumberEU/1/13/871/001-003

Group Information

ATC CodeG03GA Gonadotropins
G03GA05 follitropin alfa

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back